Sign Up | Log In | What is SocialPicks?

Cerus Corp. (CERS) Trade Now » Rate CERS - Discuss CERS - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

77.5%

Top:

0.0%

Rate CERS:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

CERS Analysis & Videos »

... View All >

CERS: Bull or Bear?

BioMed News Bytes: GeoVax, Cerus, Discovery Labs CERS

73%

+23.83%
in 11 days

On 11/17/09, GeoVax (OTC: GOVX.OB) announced that the FDA has granted its request for a pre-IND meeting to discuss the proposed Investigational New Drug (IND) application for the Company’s therapeutic vaccine as a treatment for individuals already infected with HIV. The meeting will only take place if the Company is not satisfied or requires some clarification to the FDA's answers to the questions submitted in the pre-IND package.

<> Following the FDA response to the Pre-IND meeting questions, GeoVax will prepare and submit to the FDA an IND application for the therapeutic tri...

Continue reading »

By Mike Havrilla (+1.04% risk: conservative) 11/17/09

Comment

... View All >

People Bullish on CERS

pennystocks

Analyst

N/A

2 mos ago

Penny Stocks

Analyst

N/A

2 mos ago

mvpindia

Analyst

N/A

3 mos ago

supratrader

Principal

N/A

4 mos ago

Marian Filo

Principal

62%

4 mos ago

People Bearish on CERS

Mike Havrilla

Principal

73%

10 days ago

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
IBM	International Business Machines Corp
DRYS	DryShips Inc.
SBUX	Starbucks Corp
GLD	streetTRACKS Gold
JPM	JPMorgan Chase & Co
XOM	Exxon Mobil Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

StreetInsider.com on CERS

Trading Review for Cerus Corp. Issued by Beacon Equity

Form 8-K CERUS CORP For: Nov 16

Cerus Corporation Receives FDA Blood Products Advisory Committee Guidance for Proposed INTERCEPT Blood System Phase III Trial Design

Cerus (CERS) Halted As FDA To Review Proposed Phase III Clinical Trial Design for the INTERCEPT Blood System

Cerus Corporation Stock Trading Halted; FDA Blood Products Advisory Committee to Review and Discuss Proposed Phase III Clinical Trial Design for the INTERCEPT Blood System

Discussion Wall

+ Add

amritadas (+0.00%)

A FREE report on the approval of a new Gout Drug - An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to tre

+	0 replies

... more »

More Resources

About Cerus Corp. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.